Covishield Manufacturer Serum Institute Seeks DCGI Approval To Manufacture Sputnik V Covid Vaccine

<p><strong>Covid Vaccine Update:</strong> The Serum Insititute Of India which is manufacturing the Coronavirus vaccine Covishield has sought permission from the government to manufacture the Russian vaccine Sputnik V in India. The SII has sought the DCGI&rsquo;s permission for test analysis and examination. In case, it receives a go-ahead, an emergency use authorisation (EUA) would be required.</p> <p>Russia&rsquo;s Sputnik V vaccine is currently being manufactured by Dr Reddy&rsquo;s Laboratories.</p> <p>"The&nbsp;Serum Institute of India&nbsp;(SII) put up an application to the Drugs Controller General of India (DCGI) on Wednesday seeking permission to manufacture the COVID-19 vaccine, Sputnik V, in India," a source said.</p> <p id="2" class="story_para_2">The Serum Institute plans to manufacture 100 million Covishield vaccines a month from June. Meanwhile, the SII is making Novavax vaccine, but its regulatory clearance from US is awaited.</p> <p class="story_para_2">If all goes well, Sputnik V will be the third vaccine to be manufactured by Pune-based SII after Oxford-AstraZeneca's vaccine, known as Covishield in India, and Novovax's Covovax, which has not received regulatory clearance from the US.</p> <p id="3" class="story_para_3">Recently, India received its latest consignment of nearly 3 million doses of the Sputnik V from Russia, making it the third and largest delivery of the imported Covid-19 vaccines. The doses arrived on specially-chartered freighter at Hyderabad Airport in Telangana.</p> <p class="story_para_3">Serum Institute of India which is one of the two Covid vaccine manufacturers in India has sought indemnity protection against liabilities.&nbsp;</p>

from covid-19 https://ift.tt/2TCgnbE